Global Meropenem Powder Injection Market Research Report 2024

Publication ID:

PB508243436

Publication Date:

August 12, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Meropenem Powder for Injection refers to a sterile powder form of the antibiotic meropenem that is intended for reconstitution with a suitable solvent(usually sterile water for injection)prior to intravenous administration.Meropenem is a synthetic broad-spectrum carbapenem antibiotic.It exerts a powerful antibacterial effect by inhibiting the synthesis of bacterial cell walls and has good antibacterial activity against Gram-positive bacteria,Gram-negative bacteria and anaerobic bacteria.It is often used to treat a variety of severe bacterial infections,such as pneumonia,sepsis,abdominal infections,meningitis,etc.
The global Meropenem Powder Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Meropenem Powder Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Meropenem Powder Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Meropenem Powder Injection include Intelicure Lifesciences, Pfizer, Sumitomo Pharma, CSPC Pharmaceutical Group, Joincare, Haikou Pharmaceutical Factory, Luoxin Pharna, Hisun, United Laboratories, PKU HealthCare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Meropenem Powder Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meropenem Powder Injection.
The Meropenem Powder Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Meropenem Powder Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meropenem Powder Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Intelicure Lifesciences
Pfizer
Sumitomo Pharma
CSPC Pharmaceutical Group
Joincare
Haikou Pharmaceutical Factory
Luoxin Pharna
Hisun
United Laboratories
PKU HealthCare
Chongqing Shenghuaxi Pharma
Shanghai Pharma
Segment by Type
0.25g per Vial
0.50g per Vial
1.0g per Vial
Segment by Application
Urinary Tract Infection
Meningitis
Septicemia
Skin and Soft Tissue Infections锛圫STI锛�
Gynecological Infections
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meropenem Powder Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meropenem Powder Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Meropenem Powder Injection Market Overview
1.1 Product Definition
1.2 Meropenem Powder Injection by Type
1.2.1 Global Meropenem Powder Injection Market Value Comparison by Type (2024-2030)
1.2.2 0.25g per Vial
1.2.3 0.50g per Vial
1.2.4 1.0g per Vial
1.3 Meropenem Powder Injection by Application
1.3.1 Global Meropenem Powder Injection Market Value by Application (2024-2030)
1.3.2 Urinary Tract Infection
1.3.3 Meningitis
1.3.4 Septicemia
1.3.5 Skin and Soft Tissue Infections锛圫STI锛�
1.3.6 Gynecological Infections
1.3.7 Other
1.4 Global Meropenem Powder Injection Market Size Estimates and Forecasts
1.4.1 Global Meropenem Powder Injection Revenue 2019-2030
1.4.2 Global Meropenem Powder Injection Sales 2019-2030
1.4.3 Global Meropenem Powder Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Meropenem Powder Injection Market Competition by Manufacturers
2.1 Global Meropenem Powder Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Meropenem Powder Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Meropenem Powder Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Meropenem Powder Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meropenem Powder Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meropenem Powder Injection, Product Type & Application
2.7 Global Key Manufacturers of Meropenem Powder Injection, Date of Enter into This Industry
2.8 Global Meropenem Powder Injection Market Competitive Situation and Trends
2.8.1 Global Meropenem Powder Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meropenem Powder Injection Players Market Share by Revenue
2.8.3 Global Meropenem Powder Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meropenem Powder Injection Market Scenario by Region
3.1 Global Meropenem Powder Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Meropenem Powder Injection Sales by Region: 2019-2030
3.2.1 Global Meropenem Powder Injection Sales by Region: 2019-2024
3.2.2 Global Meropenem Powder Injection Sales by Region: 2025-2030
3.3 Global Meropenem Powder Injection Revenue by Region: 2019-2030
3.3.1 Global Meropenem Powder Injection Revenue by Region: 2019-2024
3.3.2 Global Meropenem Powder Injection Revenue by Region: 2025-2030
3.4 North America Meropenem Powder Injection Market Facts & Figures by Country
3.4.1 North America Meropenem Powder Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Meropenem Powder Injection Sales by Country (2019-2030)
3.4.3 North America Meropenem Powder Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Meropenem Powder Injection Market Facts & Figures by Country
3.5.1 Europe Meropenem Powder Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Meropenem Powder Injection Sales by Country (2019-2030)
3.5.3 Europe Meropenem Powder Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meropenem Powder Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Meropenem Powder Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Meropenem Powder Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Meropenem Powder Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Meropenem Powder Injection Market Facts & Figures by Country
3.7.1 Latin America Meropenem Powder Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Meropenem Powder Injection Sales by Country (2019-2030)
3.7.3 Latin America Meropenem Powder Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Meropenem Powder Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Meropenem Powder Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Meropenem Powder Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Meropenem Powder Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meropenem Powder Injection Sales by Type (2019-2030)
4.1.1 Global Meropenem Powder Injection Sales by Type (2019-2024)
4.1.2 Global Meropenem Powder Injection Sales by Type (2025-2030)
4.1.3 Global Meropenem Powder Injection Sales Market Share by Type (2019-2030)
4.2 Global Meropenem Powder Injection Revenue by Type (2019-2030)
4.2.1 Global Meropenem Powder Injection Revenue by Type (2019-2024)
4.2.2 Global Meropenem Powder Injection Revenue by Type (2025-2030)
4.2.3 Global Meropenem Powder Injection Revenue Market Share by Type (2019-2030)
4.3 Global Meropenem Powder Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Meropenem Powder Injection Sales by Application (2019-2030)
5.1.1 Global Meropenem Powder Injection Sales by Application (2019-2024)
5.1.2 Global Meropenem Powder Injection Sales by Application (2025-2030)
5.1.3 Global Meropenem Powder Injection Sales Market Share by Application (2019-2030)
5.2 Global Meropenem Powder Injection Revenue by Application (2019-2030)
5.2.1 Global Meropenem Powder Injection Revenue by Application (2019-2024)
5.2.2 Global Meropenem Powder Injection Revenue by Application (2025-2030)
5.2.3 Global Meropenem Powder Injection Revenue Market Share by Application (2019-2030)
5.3 Global Meropenem Powder Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Intelicure Lifesciences
6.1.1 Intelicure Lifesciences Company Information
6.1.2 Intelicure Lifesciences Description and Business Overview
6.1.3 Intelicure Lifesciences Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Intelicure Lifesciences Meropenem Powder Injection Product Portfolio
6.1.5 Intelicure Lifesciences Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Meropenem Powder Injection Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sumitomo Pharma
6.3.1 Sumitomo Pharma Company Information
6.3.2 Sumitomo Pharma Description and Business Overview
6.3.3 Sumitomo Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sumitomo Pharma Meropenem Powder Injection Product Portfolio
6.3.5 Sumitomo Pharma Recent Developments/Updates
6.4 CSPC Pharmaceutical Group
6.4.1 CSPC Pharmaceutical Group Company Information
6.4.2 CSPC Pharmaceutical Group Description and Business Overview
6.4.3 CSPC Pharmaceutical Group Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio
6.4.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.5 Joincare
6.5.1 Joincare Company Information
6.5.2 Joincare Description and Business Overview
6.5.3 Joincare Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Joincare Meropenem Powder Injection Product Portfolio
6.5.5 Joincare Recent Developments/Updates
6.6 Haikou Pharmaceutical Factory
6.6.1 Haikou Pharmaceutical Factory Company Information
6.6.2 Haikou Pharmaceutical Factory Description and Business Overview
6.6.3 Haikou Pharmaceutical Factory Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio
6.6.5 Haikou Pharmaceutical Factory Recent Developments/Updates
6.7 Luoxin Pharna
6.7.1 Luoxin Pharna Company Information
6.7.2 Luoxin Pharna Description and Business Overview
6.7.3 Luoxin Pharna Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Luoxin Pharna Meropenem Powder Injection Product Portfolio
6.7.5 Luoxin Pharna Recent Developments/Updates
6.8 Hisun
6.8.1 Hisun Company Information
6.8.2 Hisun Description and Business Overview
6.8.3 Hisun Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hisun Meropenem Powder Injection Product Portfolio
6.8.5 Hisun Recent Developments/Updates
6.9 United Laboratories
6.9.1 United Laboratories Company Information
6.9.2 United Laboratories Description and Business Overview
6.9.3 United Laboratories Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 United Laboratories Meropenem Powder Injection Product Portfolio
6.9.5 United Laboratories Recent Developments/Updates
6.10 PKU HealthCare
6.10.1 PKU HealthCare Company Information
6.10.2 PKU HealthCare Description and Business Overview
6.10.3 PKU HealthCare Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PKU HealthCare Meropenem Powder Injection Product Portfolio
6.10.5 PKU HealthCare Recent Developments/Updates
6.11 Chongqing Shenghuaxi Pharma
6.11.1 Chongqing Shenghuaxi Pharma Company Information
6.11.2 Chongqing Shenghuaxi Pharma Description and Business Overview
6.11.3 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio
6.11.5 Chongqing Shenghuaxi Pharma Recent Developments/Updates
6.12 Shanghai Pharma
6.12.1 Shanghai Pharma Company Information
6.12.2 Shanghai Pharma Description and Business Overview
6.12.3 Shanghai Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Pharma Meropenem Powder Injection Product Portfolio
6.12.5 Shanghai Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meropenem Powder Injection Industry Chain Analysis
7.2 Meropenem Powder Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meropenem Powder Injection Production Mode & Process
7.4 Meropenem Powder Injection Sales and Marketing
7.4.1 Meropenem Powder Injection Sales Channels
7.4.2 Meropenem Powder Injection Distributors
7.5 Meropenem Powder Injection Customers
8 Meropenem Powder Injection Market Dynamics
8.1 Meropenem Powder Injection Industry Trends
8.2 Meropenem Powder Injection Market Drivers
8.3 Meropenem Powder Injection Market Challenges
8.4 Meropenem Powder Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Intelicure Lifesciences
Pfizer
Sumitomo Pharma
CSPC Pharmaceutical Group
Joincare
Haikou Pharmaceutical Factory
Luoxin Pharna
Hisun
United Laboratories
PKU HealthCare
Chongqing Shenghuaxi Pharma
Shanghai Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂